Bank Of Stockton Edwards Lifesciences Corp Transaction History

Bank Of Stockton

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 27, 2022	SELL	$101.96 - $128.34 $159,057 - $200,210	-1,560 Closed	0 $0
Q4 2021 Feb 07, 2022	BUY	$106.37 - $130.68 $165,937 - $203,860	1,560 New	1,560 $202,000
Q4 2020 Jan 28, 2021	SELL	$71.69 - $91.23 $264,177 - $336,182	-3,685 Closed	0 $0
Q2 2020 Jul 23, 2020	BUY	$57.54 - $76.95 $212,034 - $283,560	3,685 New	3,685 $254,000
Q1 2020 Apr 07, 2020	SELL	$52.41 - $81.0 $50,837 - $78,570	-970 Closed	0 $0
Q3 2019 Oct 24, 2019	BUY	$61.55 - $75.43 $59,703 - $73,167	970 New	970 $213,000
Q2 2019 Jul 26, 2019	SELL	$55.74 - $64.41 $59,641 - $68,918	-1,070 Closed	0 $0
Q1 2019 Apr 17, 2019	BUY	$47.89 - $64.05 $51,242 - $68,533	1,070 New	1,070 $204,000

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Bank Of Stockton, based on Form 13F filings with the SEC.

Stay updated on Bank Of Stockton with notifications on news.